About me
Dr. Oliveria's career as a pharmacoepidemiologist spans more than 25 years in academia, industry, and non-profit settings. She is trained as a pharmacoepidemiologist, having received her Doctor of Science from the Harvard School of Public Health. In her current role she leads the scientific teams and activities focused on generating real-world evidence and peri- and post-approval studies to support the value of drugs and devices throughout their development and lifecycle management at Thermo Fisher Scientific. She is a member of medical and scientific societies and has held leadership roles with the International Society for Pharmacoepidemiology (ISPE).
